Fabrizio Rinaldi, PhD, Scientist in Stem Cell Research and Development, Bio-Techne
Tim Manning, PhD, Proteins Product Manager, Bio-Techne
As induced pluripotent stem cells continue progress towards cell therapy use to treat neurodegenerative disease, diabetes, vision impairment, and heart repair, there are critical questions and steps for maintaining cell quality and consistency that need to be considered. This webinar is designed to get researchers thinking about the best ways to control the quality and consistency of a stem cell therapy as it begins its therapeutic transition. The first part of the webinar introduces methods and tips to efficiently validate and assess variability across human iPS cell lines, a critical step for controlling quality within iPS cell translation. The second half...
